Pazopanib therapy for desmoid tumors in adolescent and young adult patients.
Laura AgrestaHee KimBrian K TurpinRajaram NagarajanAlexandra PlemmonsSara SzaboRoshni DasguptaJoel I SorgerJoseph G PresseyPublished in: Pediatric blood & cancer (2018)
Pazopanib provides a promising, well-tolerated therapy for DT/AF in the AYA population and warrants further study.